Impaired Sulfate Metabolism and Epigenetics: Is There a Link in Autism?
暂无分享,去创建一个
[1] H. Nader,et al. Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates. , 2000, Biochimica et biophysica acta.
[2] Mark Lucock,et al. G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. , 2005, Life sciences.
[3] Suzanne McDermott,et al. Pre-Eclampsia, Birth Weight, and Autism Spectrum Disorders , 2010, Journal of autism and developmental disorders.
[4] Clive Osmond,et al. Impaired Insulin Secretion After Prenatal Exposure to the Dutch Famine A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.
[5] Karoly Horvath,et al. Autism and gastrointestinal symptoms , 2002, Current gastroenterology reports.
[6] Lisa M Bodnar,et al. Maternal vitamin D deficiency increases the risk of preeclampsia. , 2007, The Journal of clinical endocrinology and metabolism.
[7] Mark D. Shriver,et al. The 8818G allele of the agouti signaling protein (ASIP) gene is ancestral and is associated with darker skin color in African Americans , 2005, Human Genetics.
[8] David W Gaylor,et al. Abnormal Transmethylation/transsulfuration Metabolism and DNA Hypomethylation Among Parents of Children with Autism , 2008, Journal of autism and developmental disorders.
[9] Charles E. Schwartz,et al. High frequency of neurexin 1β signal peptide structural variants in patients with autism , 2006, Neuroscience Letters.
[10] H. M. Geller,et al. Chondroitin sulfate proteoglycans in neural development and regeneration , 2005, Current Opinion in Neurobiology.
[11] P. Whiteley,et al. Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention , 2002, Expert opinion on therapeutic targets.
[12] Linda C. Schmidt,et al. Prenatal Vitamins, One-carbon Metabolism Gene Variants, and Risk for Autism , 2011, Epidemiology.
[13] Konstantinos Francis,et al. Novel therapeutic targets for autism. , 2008, Trends in pharmacological sciences.
[14] D. Laraque,et al. Autism and developmental abnormalities in children with perinatal cocaine exposure. , 1992, Journal of the National Medical Association.
[15] N. Klein,et al. Disruption of sulphated glycosaminoglycans in intestinal inflammation , 1993, The Lancet.
[16] K. Mccully,et al. Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases. , 2011, Annals of clinical and laboratory science.
[17] R. Deth,et al. How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis. , 2008, Neurotoxicology.
[18] W. Sessa,et al. Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough? , 2001, The Journal of pharmacology and experimental therapeutics.
[19] Tanya M. Teslovich,et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. , 2008, American journal of human genetics.
[20] Christopher Gillberg,et al. Prevalence of autism in children born to Somali parents living in Sweden: a brief report , 2008, Developmental medicine and child neurology.
[21] C. Falany,et al. Expression and Localization of Cytosolic Sulfotransferase (SULT) 1A1 and SULT1A3 in Normal Human Brain , 2009, Drug Metabolism and Disposition.
[22] Kim L R Brouwer,et al. Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[23] Patricia M. Whitaker-Azmitia,et al. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? , 2005, International Journal of Developmental Neuroscience.
[24] Takuya Takizawa,et al. The Efflux Transport of Dehydroepiandrosterone Sulfate at the Blood-Brain Barrier , 2000 .
[25] Stefano Bonassi,et al. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. , 2012, Free radical biology & medicine.
[26] Rubina A Karatela,et al. Plasma homocysteine in obese, overweight and normal weight hypertensives and normotensives. , 2009, Indian heart journal.
[27] W. Dröge,et al. Glutathione and immune function , 2000, Proceedings of the Nutrition Society.
[28] E. Mosharov,et al. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. , 2000, Biochemistry.
[29] Stephanie Seneff,et al. Might cholesterol sulfate deficiency contribute to the development of autistic spectrum disorder? , 2012, Medical hypotheses.
[30] A. Chauhan,et al. Oxidative stress in autism. , 2006, Pathophysiology : the official journal of the International Society for Pathophysiology.
[31] K. Muegge,et al. DNA methylation in early development , 2010, Molecular reproduction and development.
[32] George M. Anderson,et al. Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects , 1987, Biological Psychiatry.
[33] C. Barthélémy,et al. Vitamin B6, magnesium, and combined B6-Mg: Therapeutic effects in childhood autism , 1985, Biological Psychiatry.
[34] Carl Feinstein,et al. Oxytocin and autistic disorder: alterations in peptide forms , 2001, Biological Psychiatry.
[35] David A Geier,et al. A prospective assessment of androgen levels in patients with autistic spectrum disorders: biochemical underpinnings and suggested therapies. , 2007, Neuro endocrinology letters.
[36] Caroline A. Macera,et al. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder , 2008, Autism : the international journal of research and practice.
[37] R L Blaylock,et al. Immune-glutamatergic dysfunction as a central mechanism of the autism spectrum disorders. , 2009, Current medicinal chemistry.
[38] A. Beitz,et al. Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma‐1 and GABAA receptors , 2009, British journal of pharmacology.
[39] Ping Zhu,et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells , 2001, The EMBO journal.
[40] R Day,et al. Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. , 2001, The Journal of pediatrics.
[41] D. Williams,et al. Membrane cholesterol modulates serotonin transporter activity. , 2001, Biochemistry.
[42] Paul A Dawson,et al. Sulfate in fetal development. , 2011, Seminars in cell & developmental biology.
[43] Hieronim Jakubowski,et al. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone. , 2010, Advances in experimental medicine and biology.
[44] Tianyan Zhou,et al. Genistein induction of human sulfotransferases in HepG2 and Caco-2 cells. , 2008, Basic & clinical pharmacology & toxicology.
[45] D. Markovich,et al. Identification of a mammalian brain sulfate transporter. , 1999, Biochemical and biophysical research communications.
[46] Paul A Dawson,et al. NaSi-1 and Sat-1: structure, function and transcriptional regulation of two genes encoding renal proximal tubular sulfate transporters. , 2005, The international journal of biochemistry & cell biology.
[47] L. Allen,et al. Causes of Vitamin B12 and Folate Deficiency , 2008, Food and nutrition bulletin.
[48] A. Ylinen,et al. Reg1ulatory Role and Molecular Interactions of a Cell-Surface Heparan Sulfate Proteoglycan (N-syndecan) in Hippocampal Long-Term Potentiation , 1999, The Journal of Neuroscience.
[49] J. Wilkinson,et al. The role of the agouti gene in the yellow obese syndrome. , 1997, The Journal of nutrition.
[50] Donna Spiegelman,et al. Prenatal risk factors for autism: comprehensive meta-analysis , 2009, British Journal of Psychiatry.
[51] N. Jiang,et al. Inhibition of nitric oxide synthase by cobalamins and cobinamides. , 2009, Free radical biology & medicine.
[52] W. Grant,et al. Epidemiologic evidence for supporting the role of maternal vitamin D deficiency as a risk factor for the development of infantile autism , 2009, Dermato-endocrinology.
[53] Takeshi Sakurai,et al. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders , 2009, Trends in Neurosciences.
[54] Pei-Hua Lu,et al. [Chondroitin sulfate proteoglycans in neural development and regeneration]. , 2007, Sheng li ke xue jin zhan [Progress in physiology].
[55] Yuko Higashi,et al. Cholesterol sulfate in human physiology: what's it all about? , 2003, Journal of lipid research.
[56] A Braconnier,et al. Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. , 1988, Neuropsychobiology.
[57] Janet K. Kern,et al. A Prospective Study of Transsulfuration Biomarkers in Autistic Disorders , 2009, Neurochemical Research.
[58] S. Nozawa,et al. Alteration of acidic lipids in human sera during the course of pregnancy: characteristic increase in the concentration of cholesterol sulfate. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[59] H. Takanaga,et al. Blood—Brain Barrier Is Involved in the Efflux Transport of a Neuroactive Steroid, Dehydroepiandrosterone Sulfate, via Organic Anion Transporting Polypeptide 2 , 2000, Journal of neurochemistry.
[60] W. B. van den Berg,et al. High susceptibility of human articular cartilage glycosaminoglycan synthesis to changes in inorganic sulfate availability , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[61] A. Polge,et al. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism. , 2006, Magnesium research.
[62] A. Polge,et al. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. , 2006, Magnesium research.
[63] J. Sebat,et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. , 2008, American journal of human genetics.
[64] Guoping Fan,et al. DNA methylation controls the timing of astrogliogenesis through regulation of JAK-STAT signaling , 2005, Development.
[65] R. Waring,et al. Enzyme and sulphur oxidation deficiencies in autistic children with known food intolerances. , 1993 .
[66] D. Dolinoy,et al. The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome. , 2008, Nutrition reviews.
[67] B. Nemeș,et al. High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autism. , 2006, Life sciences.
[68] Marko Kaksonen,et al. Syndecan-3-Deficient Mice Exhibit Enhanced LTP and Impaired Hippocampus-Dependent Memory , 2002, Molecular and Cellular Neuroscience.
[69] P. Ashwood,et al. The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.
[70] E R Martin,et al. Association Analysis of Chromosome 15 GABAA Receptor Subunit Genes in Autistic Disorder , 2001, Journal of neurogenetics.
[71] Abraham Weizman,et al. Lowered DHEA-S plasma levels in adult individuals with autistic disorder , 2005, European Neuropsychopharmacology.
[72] C. Falany,et al. Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7. , 1993, Genomics.
[73] Lutz Edler,et al. Improvement of immune functions in HIV infection by sulfur supplementation: Two randomized trials , 2000, Journal of Molecular Medicine.
[74] Ruma Banerjee,et al. Testosterone regulation of homocysteine metabolism modulates redox status in human prostate cancer cells. , 2007, Antioxidants & redox signaling.
[75] A. El-Ansary,et al. Novel metabolic biomarkers related to sulfur-dependent detoxification pathways in autistic patients of Saudi Arabia , 2011, BMC neurology.
[76] Otilia Catanescu,et al. Homocysteine is transported by the microvillous plasma membrane of human placenta , 2011, Journal of Inherited Metabolic Disease.
[77] W. Reik. Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.
[78] Henry Markram,et al. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid , 2007, Proceedings of the National Academy of Sciences.
[79] I. Korf,et al. Large-scale methylation domains mark a functional subset of neuronally expressed genes. , 2011, Genome research.
[80] V. Rakyan,et al. Transgenerational inheritance of epigenetic states at the murine AxinFu allele occurs after maternal and paternal transmission , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[81] Ken Eagle,et al. Toxicological effects of red wine, orange juice, and other dietary SULT1A inhibitors via excess catecholamines. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[82] Orit Pappo,et al. Hepatic effects of rosiglitazone in rats with the metabolic syndrome. , 2010, Basic & clinical pharmacology & toxicology.
[83] I. Pogribny,et al. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. , 2001, The Journal of nutrition.
[84] S. J. James,et al. Cerebral folate receptor autoantibodies in autism spectrum disorder , 2012, Molecular Psychiatry.
[85] Stepan Melnyk,et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[86] E. Tierney,et al. Cholesterol Deficit in Autism: Insights from Smith–Lemli–Opitz Syndrome , 2008 .
[87] Robert T. Schultz,et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders , 2009, Nature.
[88] A. Meister,et al. Glutathione is required for intestinal function. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[89] G. Stoner,et al. Cholesterol sulfate accumulation in tumorigenic and nontumorigenic rat esophageal epithelial cells: evidence for defective differentiation control in tumorigenic cells. , 1988, Cancer research.
[90] Y. Yamaguchi,et al. Heparan sulfate proteoglycans in the nervous system: their diverse roles in neurogenesis, axon guidance, and synaptogenesis. , 2001, Seminars in cell & developmental biology.
[91] C. Klaassen,et al. Different mechanism of saturation of acetaminophen sulfate conjugation in mice and rats. , 1996, Toxicology and applied pharmacology.
[92] Janet K. Kern,et al. Biomarkers of environmental toxicity and susceptibility in autism , 2009, Journal of the Neurological Sciences.
[93] Paula Krakowiak,et al. Maternal Metabolic Conditions and Risk for Autism and Other Neurodevelopmental Disorders , 2012, Pediatrics.
[94] Maurizio Elia,et al. Sulphation deficit in “low-functioning” autistic children: a pilot study , 1999, Biological Psychiatry.
[95] Janine M. LaSalle,et al. A genomic point-of-view on environmental factors influencing the human brain methylome , 2011, Epigenetics.
[96] Janet K. Kern,et al. An evaluation of the role and treatment of elevated male hormones in autism spectrum disorders. , 2012, Acta neurobiologiae experimentalis.
[97] Bess Dawson-Hughes,et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. , 2007, The Journal of clinical endocrinology and metabolism.
[98] Keiji Morokuma,et al. Zinc–Homocysteine binding in cobalamin‐dependent methionine synthase and its role in the substrate activation: DFT, ONIOM, and QM/MM molecular dynamics studies , 2011, J. Comput. Chem..
[99] S. Mennerick,et al. Hydrophobic anions potently and uncompetitively antagonize GABAA receptor function in the absence of a conventional binding site , 2011, British journal of pharmacology.
[100] C. Klaassen,et al. The importance of 3‘‐phosphoadenosine 5‘‐phosphosulfate (PAPS) in the regulation of sulfation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[101] Dennis P Wall,et al. Heparan sulfate proteoglycans and the emergence of neuronal connectivity , 2006, Current Opinion in Neurobiology.
[102] T. Kemper,et al. Density and Distribution of Hippocampal Neurotransmitter Receptors in Autism: An Autoradiographic Study , 2001, Journal of autism and developmental disorders.
[103] R. Waterland,et al. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. , 2004, Nutrition.
[104] J. Baio. Morbidity and Mortality Weekly Report Prevalence of Autism Spectrum Disorders — Autism and Developmental Disabilities Monitoring Network, Six Sites, United States, 2000; Prevalence of Autism Spectrum Disorders — Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2002; , 2007 .
[105] Y. Yamaguchi,et al. Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate , 2012, Proceedings of the National Academy of Sciences.
[106] D. Conrad,et al. Recurrent 16p11.2 microdeletions in autism. , 2007, Human molecular genetics.
[107] Christian Biémont,et al. Genetics: Junk DNA as an evolutionary force , 2006, Nature.
[108] Stephanie Seneff,et al. The Initial Common Pathway of Inflammation, Disease, and Sudden Death , 2012, Entropy.
[109] David W. Gaylor,et al. A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[110] P. Grattan-Smith,et al. The neurological syndrome of infantile cobalamin deficiency: Developmental regression and involuntary movements , 1997, Movement disorders : official journal of the Movement Disorder Society.
[111] Janet K. Kern,et al. A clinical trial of glutathione supplementation in autism spectrum disorders , 2011, Medical science monitor : international medical journal of experimental and clinical research.
[112] A. Gürel,et al. Nitric oxide as a physiopathological factor in neuropsychiatric disorders. , 2004, In vivo.
[113] Paul T Martin,et al. Glycobiology of the synapse. , 2002, Glycobiology.
[114] L. Matherly,et al. Molecular and cellular biology of the human reduced folate carrier. , 2001, Progress in nucleic acid research and molecular biology.
[115] Victoria Arija,et al. Maternal homocysteine before conception and throughout pregnancy predicts fetal homocysteine and birth weight. , 2004, Clinical chemistry.
[116] David W Gaylor,et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. , 2004, The American journal of clinical nutrition.
[117] H. Savaş,et al. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[118] J. Mason,et al. Activation of methionine synthase by insulin-like growth factor-1 and dopamine: a target for neurodevelopmental toxins and thimerosal , 2004, Molecular Psychiatry.
[119] Wei Zheng,et al. Critical role of vitamin D in sulfate homeostasis: regulation of the sodium-sulfate cotransporter by 1,25-dihydroxyvitamin D3. , 2004, American journal of physiology. Endocrinology and metabolism.
[120] Leslie Roberts,et al. Controversial From the Start , 2001, Science.
[121] Mari S Golub,et al. Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. , 2012, Human molecular genetics.
[122] Marwan Shinawi,et al. The MTHFR 677C→T polymorphism and behaviors in children with autism: exploratory genotype–phenotype correlations , 2009, Autism research : official journal of the International Society for Autism Research.
[123] David A. Geier,et al. A Clinical and Laboratory Evaluation of Methionine Cycle-Transsulfuration and Androgen Pathway Markers in Children with Autistic Disorders , 2006, Hormone Research in Paediatrics.
[124] Guoping Fan,et al. DNA hypomethylation restricted to the murine forebrain induces cortical degeneration and impairs postnatal neuronal maturation. , 2009, Human molecular genetics.
[125] R. Jirtle,et al. Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.
[126] David Wallinga,et al. A macroepigenetic approach to identify factors responsible for the autism epidemic in the United States , 2012, Clinical Epigenetics.
[127] J. Stockman. Association between Microdeletion and Microduplication at 16p11.2 and Autism , 2009 .
[128] Christopher Gillberg,et al. Increased rate of twins among affected sibling pairs with autism. , 2002, American journal of human genetics.
[129] Theoharis C Theoharides,et al. Neuro-inflammation, blood-brain barrier, seizures and autism , 2011, Journal of Neuroinflammation.
[130] Martin Renqiang Min,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[131] Stepan Melnyk,et al. Trans-HHS Workshop : Diet , DNA Methylation Processes and Health Elevation in S-Adenosylhomocysteine and DNA Hypomethylation : Potential Epigenetic Mechanism for Homocysteine-Related Pathology 1 , 2002 .
[132] Dominique Bondoux,et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives , 1999, Biological Psychiatry.
[133] Patricia M. Whitaker-Azmitia,et al. Serotonin and brain development: role in human developmental diseases , 2001, Brain Research Bulletin.
[134] M. Brosnan,et al. Methylation demand: a key determinant of homocysteine metabolism. , 2004, Acta biochimica Polonica.
[135] J. A. Laurence,et al. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects , 2008, The Cerebellum.
[136] B. Seetharam,et al. Cellular import of cobalamin (Vitamin B-12). , 1999, The Journal of nutrition.
[137] J. Baio. Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. , 2012, Morbidity and mortality weekly report. Surveillance summaries.
[138] Matthew W. Mosconi,et al. Consensus Paper: Pathological Role of the Cerebellum in Autism , 2012, The Cerebellum.
[139] R. Waring,et al. Sulphur metabolism in autism. , 2000 .